Contrafect Corp (CFRX): Sell the news. Costs money to run Phas...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: 420man post# 74

Tuesday, 01/08/2019 2:45:50 PM

Tuesday, January 08, 2019 2:45:50 PM

Sell the news.
Costs money to run Phase 3 trials.

Keep Last Read

Replies (1) Next 10 Prev Next

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:24:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:41:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:30:55 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/03/2023 09:08:09 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/03/2023 04:16:01 AM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/30/2023 09:24:34 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/24/2023 08:06:07 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/23/2023 08:05:56 PM
ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study • GlobeNewswire Inc. • 10/16/2023 11:30:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 03:15:52 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/25/2023 12:00:18 PM

InvestorsHub NewsWire

Only $200 per official company press release!